She's not talking about Obamacare, but the entire health care system of America in total.
---
As noted earlier, following a feverish push by Congress and Hillary Clinton to scapegoat Mylan, and its CEO, Heather Bresch, as “greedy” examples of corporatism (even though it is not Mylan’s fault it is a de facto monopoly and thus has unlimited pricing ability), the EpiPen maker on Thursday announced plans to boost access to its EpiPen Auto-Injector by expanding already existing programs for patients who are facing higher out-of-pocket costs.
Really now? Being granted near monopoly status strips you, as a person, from being able to make the moral choice? That there was a rider in the government actions that stated your company *MUST* raise the price irregardless of the cot of the goods involved?
I think the author of this piece needs help.